Impaired Glucose Tolerance Clinical Trials

6 recruiting

Impaired Glucose Tolerance Trials at a Glance

13 actively recruiting trials for impaired glucose tolerance are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Atlanta, Durham, and Jacksonville. Lead sponsors running impaired glucose tolerance studies include Georgia State University, Instituto de Ciencia y Tecnología de Alimentos y Nutrición, and Aarhus University Hospital.

Browse impaired glucose tolerance trials by phase

Treatments under study

About Impaired Glucose Tolerance Clinical Trials

Looking for clinical trials for Impaired Glucose Tolerance? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Impaired Glucose Tolerance trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Impaired Glucose Tolerance clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting
Phase 2

Efficacy and Safety of Oral Controlled-release Nicotinic Acid (CIR-NA) for the Remission of Prediabetes. (CONCEPT)

Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
University Hospital Schleswig-Holstein390 enrolled2 locationsNCT07286747
Recruiting
Not Applicable

Probiotic Impact on Cognitive Performance, and Metabolic Outcomes in Overweight Young Adults With Impaired Glucose Regulation

Cognitive DysfunctionPrediabetes (Insulin Resistance, Impaired Glucose Tolerance)Overweight (BMI > 25)+3 more
Leeds Beckett University70 enrolled1 locationNCT07073781
Recruiting
Not Applicable

Peanuts for Cardiometabolic, Brain, and Intestinal Health

AdultPrediabetesCognition+5 more
Georgia State University72 enrolled1 locationNCT06867198
Recruiting
Not Applicable

Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes

Arterial StiffnessBody CompositionAdult+9 more
Georgia State University30 enrolled1 locationNCT06735651
Recruiting
Not Applicable

CGM and Lifestyle Changes in Patients With Impaired Glucose Tolerance

PrediabetesImpaired Glucose Tolerance
Nemours Children's Clinic15 enrolled1 locationNCT05387551
Recruiting
Not Applicable

Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)

Diabetes Mellitus, Type 2Impaired Glucose Tolerance (IGT)Impaired Fasting Glucose (IFG)
The University of Texas Health Science Center at San Antonio700 enrolled1 locationNCT02969798
Recruiting
Early Phase 1

Efficacy and Safety of Sanggua Tablets in the Treatment of Patients With Impaired Glucose Tolerance and Mild Type 2 Diabetes

Diabetes Mellitus, Type 2Impaired Glucose Tolerance
Tongji Hospital84 enrolled1 locationNCT06964620
Recruiting
Phase 2

Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver DiseaseImpaired Glucose ToleranceType 2 Diabetes Mellitus+1 more
Yale University60 enrolled1 locationNCT05067621
Recruiting
Not Applicable

Antidiabetic Effect of Olive Pomace Oil

Diabetes MellitusDiabetesType 2 Diabetes Mellitus+2 more
Instituto de Ciencia y Tecnología de Alimentos y Nutrición50 enrolled1 locationNCT06723886
Recruiting

Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents With ALL and Lymphoma

LymphomaPrecursor Cell Lymphoblastic Leukemia-LymphomaDrug-Induced Diabetes Mellitus+1 more
Aarhus University Hospital100 enrolled1 locationNCT05873322
Recruiting
Not Applicable

The Effects of an Obesogenic Lifestyle in Recreationally Active, Young Adults

Metabolic DisturbanceObesityInsulin Resistance+1 more
University of New Hampshire45 enrolled1 locationNCT05912348
Recruiting
Phase 2

Elucidating the Effects of Tocotrienol rich Vitamin E on Metabolic Biomarkers in a Pre-diabetes Population in Malaysia.

PrediabetesImpaired Glucose ToleranceImpaired fasting glucose
Monash University Malaysia80 enrolled2 locationsACTRN12622000256774
Recruiting
Phase 4

Can Calcium and Vitamin D reduce diabetes risk in people at high risk?

Pre-diabetes (impaired fasting glucose or impaired glucose tolerance)Obesity
Professor Peter Ebeling160 enrolled1 locationACTRN12609000043235